These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18928670)

  • 1. Human papillomavirus testing for primary cervical cancer screening.
    Runowicz CD; Garozzo S
    Curr Oncol Rep; 2008 Nov; 10(6):533-7. PubMed ID: 18928670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of human papillomavirus DNA in routine cervical scraping samples: use for a national cervical cancer screening program in a developing nation.
    Othman N; Othman NH
    Asian Pac J Cancer Prev; 2014; 15(5):2245-9. PubMed ID: 24716964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Australian women's needs and preferences for information about human papillomavirus in cervical screening.
    McCaffery K; Irwig L
    J Med Screen; 2005; 12(3):134-41. PubMed ID: 16156944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chapter 13: Primary screening of cervical cancer with human papillomavirus tests.
    Franco EL
    J Natl Cancer Inst Monogr; 2003; (31):89-96. PubMed ID: 12807951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of initial stream urine samples and cervical samples for detection of human papillomavirus.
    Hagihara M; Yamagishi Y; Izumi K; Miyazaki N; Suzuki T; Kato H; Nishiyama N; Koizumi Y; Suematsu H; Mikamo H
    J Infect Chemother; 2016 Aug; 22(8):559-62. PubMed ID: 27342077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.
    Schiffman M; Kinney WK; Cheung LC; Gage JC; Fetterman B; Poitras NE; Lorey TS; Wentzensen N; Befano B; Schussler J; Katki HA; Castle PE
    J Natl Cancer Inst; 2018 May; 110(5):501-508. PubMed ID: 29145648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of self-collection devices for cytology and human papillomavirus DNA testing in cervical cancer screening.
    Bidus MA; Zahn CM; Maxwell GL; Rodriguez M; Elkas JC; Rose GS
    Clin Obstet Gynecol; 2005 Mar; 48(1):127-32. PubMed ID: 15725865
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cervical cancer screning: from cytology to HPV testing].
    Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):289-292. PubMed ID: 31154708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV testing in cervical cytology practice: it's all about choice.
    Stoler MH
    Acta Cytol; 2005; 49(2):117-9. PubMed ID: 15839612
    [No Abstract]   [Full Text] [Related]  

  • 10. Human papillomavirus DNA testing for cervical cancer screening: practical aspects in developing countries.
    Belinson SE; Belinson JL
    Mol Diagn Ther; 2010 Aug; 14(4):215-22. PubMed ID: 20799763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
    Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
    Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer screening in the early post vaccine era.
    Waxman AG
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):537-48; vii. PubMed ID: 19061815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer.
    Ogilvie GS; Krajden M; van Niekerk D; Smith LW; Cook D; Ceballos K; Lee M; Gentile L; Gondara L; Elwood-Martin R; Peacock S; Stuart G; Franco EL; Coldman AJ
    Int J Cancer; 2017 Jan; 140(2):440-448. PubMed ID: 27685757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
    Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
    Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).
    Mayrand MH; Duarte-Franco E; Coutlée F; Rodrigues I; Walter SD; Ratnam S; Franco EL;
    Int J Cancer; 2006 Aug; 119(3):615-23. PubMed ID: 16572425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV testing in liquid specimens.
    Geyer SJ
    Acta Cytol; 2006; 50(5):599-600. PubMed ID: 17017457
    [No Abstract]   [Full Text] [Related]  

  • 17. Adding human papillomavirus testing to cytology for primary cervical cancer screening: shooting first and asking questions later.
    Sawaya GF
    Ann Intern Med; 2008 Apr; 148(7):557-9. PubMed ID: 18378951
    [No Abstract]   [Full Text] [Related]  

  • 18. Urine-based HPV testing as a method to screen for cervical cancer.
    Fontenot HB
    Nurs Womens Health; 2015; 19(1):59-65. PubMed ID: 25690816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions.
    Ducancelle A; Legrand MC; Pivert A; Veillon P; Le Guillou-Guillemette H; De Brux MA; Beby-Defaux A; Agius G; Hantz S; Alain S; Catala L; Descamps P; Postec E; Caly H; Charles-Pétillon F; Labrousse F; Lunel F; Payan C
    Arch Gynecol Obstet; 2014 Aug; 290(2):299-308. PubMed ID: 24622934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary human papillomavirus testing in organized cervical screening.
    Dillner J
    Curr Opin Obstet Gynecol; 2013 Feb; 25(1):11-6. PubMed ID: 23299089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.